A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of SPI Implant

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

88 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-11-30

Study Completion Date

2017-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The current prospective clinical study's aim is to determine ABT's SPI implant survival rate, crestal interproximal bone resorption during 24 months post implant insertion and to assimilate the drilling sequence during the clinical use of SPI implants.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of ICE Implant

NCT01960361

Implant Clinical Survival Dental Implant Bone Loss

COMPLETED PHASE4

Evaluation of the Prevalence and Risk Factors for Patients With Peri-implant Disease：a Retrospective Study

NCT02662361

Jaw, Edentulous, Partially

UNKNOWN

Evaluation of the Prevalence and Risk Factors for Patients With Peri-implant Disease

NCT02676661

Jaw, Edentulous, Partially

UNKNOWN

Study on OsseoSpeed™ TX Implants in a Chinese Population

NCT01346683

Partially Edentulous Jaw

COMPLETED NA

Two-piece Versus Single-piece Patient-specific Titanium Subperiosteal Implants

NCT03242330

Dental Implant

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Implant Clinical Survival Dental Implant Bone Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SPI dental implant

Subjects implanted with SPI implant

Group Type EXPERIMENTAL

SPI implant

Intervention Type DEVICE

SPI implant - the original spiral implant

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SPI implant

SPI implant - the original spiral implant

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Men and women over the age of 18 years who need implantation of 1-4 implants.
2. Patients who are able to understand the requirements of the study, and are willing and able to comply with its instructions and schedules.
3. Patients who had provided written informed consent to participate in the study prior to any study procedure.
4. Patients in general good health in the opinion of the principal investigator as determined by medical history and oral examination.

Exclusion Criteria

1. Immediate loaded implants.
2. Patient requiring bone augmentation
3. Treatment with anticoagulant drugs (INR under 1.8) or bisphosphonates.
4. Treatment with anticonvulsants drugs.
5. Untreated Periodontal disease and inability of the patient to maintain reasonable oral hygiene according to study requirements.
6. Patients with history of alcohol, narcotics or drug abuse.
7. Patients under steroid therapy.
8. Patients receiving radiotherapy, chemotherapy or any other immunosuppressive treatment or who have been administered radiotherapy in the last 5 years.

Patients through at anytime received radiotherapy to the head and neck region will be excluded anyway.
9. Metabolic bone disorders and/or bone augmentation.
10. Uncontrolled bleeding disorders such as: hemophilia, thrombocytopenia, granulocytopenia.
11. Degenerative diseases.
12. Osteoradionecrosis.
13. Renal failure.
14. Organ transplant recipients.
15. HIV positive.
16. Malignant diseases.
17. Diseases that compromise the immune system.
18. Unbalanced diabetes mellitus. (HbA1c above 6.5)
19. Psychotic diseases.
20. Hypersensitivity to one of the components of the implant in general and titanium in particular.
21. Women who are pregnant or lactating.
22. Lack of patient cooperation.
23. Uncontrolled endocrine diseases.
24. Any systemic condition that is unbalanced and therefore precludes surgical procedures.
25. Parafunctional habits.- e.g Bruxism.
26. Temporomandibular joint disease.
27. Various pathologies of the oral mucosa for example: Benign mucous pemphigoid, desquamative ginigivitis, erosive lichen planus ,malignancy of oral cavity, bolus erosive diseases of the oral mucosa.
28. Flapless procedures.

\-

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No